Description
5 mL de solución (75 mg de Omalizumab)
Carcinoma de células renales avanzado o metastásico
Prevención de eventos esqueléticos en pacientes con metástasis óseas por tumores sólidos
Bristol-Myers Squibb Company
PRINCIPIO ACTIVO: CLORHIDRATO DE AZELASTINA 0
BLENDOX TAB. 4 MG. CAJA C/20 SOMATROPINA ADN RECOMBINANTE 5 mL de solución (75SUSTANCIA: BLENDOX TAB. 4 MG. CAJA C 20 FABRICANTE: DEGORTS
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
